AgelessRx is a direct-to-consumer telehealth company founded in 2020 that provides science-backed longevity treatments aimed at enhancing healthspan. The platform offers personalized protocols, prescription therapies, diagnostics, and supplements to address the root causes of aging. It operates on a subscription-based membership model, connecting users with licensed clinicians to facilitate preventive care.
Company Values
The company positions itself as a pioneering, data-driven longevity platform that offers clinician-guided protocols that are continuously updated with patient data. A key differentiator is its operation of large, decentralized clinical trials, such as the PEARL trial for Rapamycin, which allows for real-world evidence gathering on a large scale.